MLI Coupon Plus (MLI 2019 - 01)
The product is available for subscription
The Market Linked Investment (MLI) is a 3 year Deferred Purchase Agreement product which is linked to the performance of shares in one LSE-listed company: AstraZeneca PLC (“AZL”), one NYSE-listed company: Merck & Co., Inc. (“MRK”) and one Xetra-listed company: Bayer AG (“BAYN”), each a Reference Asset, and together the Reference Assets. The MLI offers the potential for quarterly income payment of a fixed percentage. The MLI includes a Memory Autocall Event feature and a Knock-In Event feature which may terminate the product early or cause the loss of some or all of your investment amount.
Investors should read and understand the contents of the relevant Product Disclosure Statement, including the risks of investing in the MLI, and seek any relevant independent advice before making any investment decision.
For further information on structured financial products contact the Citigroup Structured Products Service Centre.